Athira Pharma (ATHA) Income Statement: Revenue & Earnings

Athira Pharma Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Athira Pharma, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	70.68	93.79	61.46	42.79	13.29
Selling, General & Administrative	26.09	33.30	32.55	21.23	6.71
Operating Expenses	96.78	127.09	94.02	64.02	20.00
Operating Income	-96.78	-125.47	-94.02	-64.02	-20.00
Other Income/Expense
Interest Income	3.96	0.00	0.00	0.34	0.12
Interest Expense	0.00	0.00	0.00	0.00	-0.37
Other Income/Expense	3.45	-7.64	7.96	-0.33	0.08
Income
Income Before Tax	-96.94	-117.83	-95.64	-63.69	-19.96
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-96.94	-117.67	-95.64	-54.85	-19.96
Net Income - Continuous Operations	-96.94	-117.67	-95.64	-54.85	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-95.81	-116.49	-93.17	-54.71	-19.99
EBIT	-96.78	-117.67	-94.02	-55.19	-20.00
Depreciation & Amortization	0.97	0.97	0.85	0.48	0.00
Earnings Per Share
Basic EPS	-25.00	-3.00	-25.00	-1.00	-17.00
Diluted EPS	-25.00	-3.00	-25.00	-1.00	-17.00
Basic Shares Outstanding	3.85	38.02	3.77	36.92	1.20
Diluted Shares Outstanding	3.85	38.02	3.77	36.92	1.20